Related: Healthcare PR pillar · Who Controls AI Answers in Healthcare? · The Citation Share Index
A new cross-industry AI citation study finds that Perplexity rewards NIH and PubMed primary sources more than any trade publication. Healthcare and pharma communications programs running only trade-press outreach are leaving half the AI citation prize on the table.
The healthcare and pharma communications playbook has been stable for fifteen years. The trade press — STAT, Endpoints News, Fierce Biotech, MedCity News, Healthcare Dive — drives clinical and dealmaking coverage. The consumer business press — The Wall Street Journal, Bloomberg, The New York Times — drives reputation and policy. The medical journals operate on a separate plane, owned by the science teams rather than the comms function.
A new cross-industry AI citation study released this week by 5W AI Communications finds that the two-tier model is now structurally incomplete. AI engines treat primary sources — NIH-indexed studies, PubMed-indexed peer review, FDA filings — as first-class citation assets in a way no PR program currently optimizes for.
Companion analysis: This piece sits inside EPR's Healthcare PR pillar. The retrieval-side hub is Who Controls AI Answers in Healthcare?. The discipline definition is What Healthcare GEO Is, Why It Replaced Healthcare SEO. The patient-access angle is The AI Era Has a Front Door for Healthcare. The trust-and-crisis frame is in Crisis Communication in Healthcare.
Healthcare appears as Chapter 5 of the Trade Press AI Index 2026. The findings inside the vertical:
STAT has the strongest LLM parametric recall in healthcare — cross-cited across The New York Times, The Wall Street Journal, Bloomberg, and The New England Journal of Medicine context in the training and retrieval data. The trade title most healthcare CCOs already prioritize is the right priority. Endpoints News dominates biotech and pharma deal coverage citations across multiple engines. Fierce Biotech holds clinical-trial and drug-development citation queries. This much is intuitive and aligned with current healthcare PR practice.
What is not intuitive — and where current practice is failing — is the second strategy the Index identifies.
Perplexity rewards NIH and PubMed primary sources more than any trade publication. A healthcare PR program optimized for trade-press placement is winning the half of the AI citation layer that runs through editorial sources. It is invisible inside the half that runs through primary-source retrieval. For Perplexity-grade healthcare visibility — and increasingly for ChatGPT and Claude on clinical and regulatory queries — the parallel strategy must include named-source primary research, peer-reviewed publication, and structured data placement in NIH and PubMed-indexed venues.
This requires the medical affairs function and the comms function to operate as a single pipeline. Most pharma and healthcare companies still separate the two — medical affairs owning the science, comms owning the press. The AI citation layer treats both as inputs to the same retrieval graph.
The Index also identifies significant white space inside healthcare. The fastest-growing prompt clusters that no trade publication currently owns: GLP-1s and metabolic health, AI in clinical workflow, payor consolidation, healthcare cybersecurity, mental health infrastructure, longevity medicine. Any healthcare publication or brand willing to publish prompt-shaped, entity-rich, schema-clean content into one of those clusters, the report argues, can claim a top-five AI citation position within nine to twelve months.
Two operational shifts the Index recommends for healthcare and pharma communications leaders.
First, build a two-track AI strategy — STAT and Endpoints for industry citation, primary-source publication for Perplexity-grade authority. The two tracks reinforce each other, but neither alone produces the full AI footprint.
Second, format-engineer all owned content for LLM extraction. Structured comparison content. Comparison tables for drug efficacy or device performance. Decision-grade headlines for executive-decision queries. Entity-rich lead sentences naming the company, the molecule, the indication, the trial phase, and the regulatory status in the first 50 words. The Axios "smart brevity" format, the Index argues, is "a structurally engineered citation asset" — and its principles apply across healthcare equally.
A Q3 2026 update will add 100 healthcare-specific primary-source queries to the proprietary measurement layer, converting the current inferred rankings into measured Citation Share across STAT, Endpoints, Fierce Biotech, MedCity News, Healthcare Dive, Modern Healthcare, and BioPharma Dive.
The full Index, including the Healthcare chapter and white-space map, is open at 5wpr.com.
Frequently Asked Questions
What's the structural gap in healthcare PR that AI citation work exposes?
Healthcare PR programs optimized for trade press (STAT, Endpoints, Fierce Biotech) win the half of the AI citation layer that runs through editorial sources. They are invisible inside the half that runs through primary-source retrieval (NIH, PubMed, FDA filings). Perplexity rewards primary sources more than any trade publication, and ChatGPT and Claude are increasingly following the same pattern on clinical and regulatory queries.
What's the two-track AI strategy the Index recommends?
Track 1: STAT, Endpoints, Fierce Biotech, MedCity News, Healthcare Dive trade-press outreach for industry citation. Track 2: named-source primary research, peer-reviewed publication, and structured data placement in NIH and PubMed-indexed venues for primary-source citation. The tracks reinforce each other but neither alone produces the full AI footprint.
What healthcare prompt clusters are unowned and available?
GLP-1s and metabolic health. AI in clinical workflow. Payor consolidation. Healthcare cybersecurity. Mental health infrastructure. Longevity medicine. The Index argues that brands and publications willing to publish prompt-shaped, entity-rich, schema-clean content into one of those clusters can claim a top-five AI citation position within nine to twelve months.
What does format-engineering for LLM extraction mean in healthcare?
Structured comparison content (drug efficacy tables, device performance comparisons). Decision-grade headlines for executive-decision queries. Entity-rich lead sentences naming the company, the molecule, the indication, the trial phase, and the regulatory status in the first 50 words. The Axios "smart brevity" format applied across healthcare communications.
Where does this piece fit in EPR's coverage?
This piece is part of EPR's Healthcare PR pillar as the canonical reference on the two-track AI strategy that healthcare communications now requires.
